Healing of leg ulcers with hydroxyurea in thalassaemia intermedia patients with associated endocrine complications
Affiliations
- PMID: 16462721
Item in Clipboard
Healing of leg ulcers with hydroxyurea in thalassaemia intermedia patients with associated endocrine complications
Pediatr Endocrinol Rev.
2004 Dec.
Abstract
We report a preliminary clinical experience in the use of hydroxyurea (HU) for the treatment of leg ulcers in thalassaemia intermedia patients with associated endocrine complications. We administered HU 1 g/day to 6 adult patients with thalassaemia intermedia for 90 days. We observed an improvement (3 patients) or healing (3 patients) of chronic leg ulcers. Recurrence was observed in the absence of maintenance therapy (2 patients). Two patients discontinued HU because of adverse effects (stomach pain and fever). No significant increase in total Hb or HbF levels occurred. In conclusion, HU appears suitable for the treatment of leg ulcers unresponsive to conventional treatment in patients with thalassaemia intermedia.
Similar articles
-
Paraplegia due to spinal cord compression by extramedullary erythropoietic tissue in a thalassaemia intermedia patient with gynecomastia secondary to cirrhosis: successful treatment with hydroxyurea.Pediatr Endocrinol Rev. 2004 Dec;2 Suppl 2:316-8. Pediatr Endocrinol Rev. 2004. PMID: 16462720
-
The activity of superoxide dismutase in hydroxyurea-treated E beta thalassemia.J Assoc Physicians India. 2002 Aug;50:1034-5. J Assoc Physicians India. 2002. PMID: 12421025
-
The effect of hydroxyurea on the coagulation system in sickle cell anemia and beta-thalassemia intermedia patients: a preliminary study.Pediatr Hematol Oncol. 2003 Sep;20(6):429-34. Pediatr Hematol Oncol. 2003. PMID: 14631615
-
Hydroxyurea in the management of thalassemia intermedia.Hemoglobin. 2009;33 Suppl 1:S177-82. doi: 10.3109/03630260903351809. Hemoglobin. 2009. PMID: 20001623 Review.
-
Hydroxyurea-induced hematological response in transfusion-independent beta-thalassemia intermedia: case series and review of literature.Pediatr Hematol Oncol. 2009 Nov;26(8):560-5. doi: 10.3109/08880010903271671. Pediatr Hematol Oncol. 2009. PMID: 19954365 Review.
Cited by
-
Leg Ulcers: A Report in Patients with Hemoglobin E Beta Thalassemia and Review of the Literature in Severe Beta Thalassemia.Acta Haematol. 2022;145(3):334-343. doi: 10.1159/000520731. Epub 2021 Nov 9. Acta Haematol. 2022. PMID: 34753145 Free PMC article. Review.
-
Management of non-transfusion-dependent thalassemia: a practical guide.Drugs. 2014 Oct;74(15):1719-29. doi: 10.1007/s40265-014-0299-0. Drugs. 2014. PMID: 25255924 Review.
-
Foetal haemoglobin inducers for reducing blood transfusion in non-transfusion-dependent beta-thalassaemias.Cochrane Database Syst Rev. 2023 Jan 13;1(1):CD013767. doi: 10.1002/14651858.CD013767.pub2. Cochrane Database Syst Rev. 2023. PMID: 36637054 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Medical